Newsroom

Sorted by: Latest

-

Xylem Inc. Announces $1.5 Billion Share Repurchase Authorization

WASHINGTON--(BUSINESS WIRE)--Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today announced that its Board of Directors has authorized a new share repurchase program of its common stock of up to $1.5 billion, effective immediately. Repurchases may be made from time to time on the open market or in privately negotiated transactions. The Company intends to be opportunistic in its repurchases of stock based on market...
-

AM Best Affirms Credit Ratings of Everest Group, Ltd and Its Subsidiaries

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “aa-” (Superior) of the operating subsidiaries of Everest Group, Ltd. (Bermuda) (collectively referred to as Everest). Concurrently, AM Best has affirmed the Long-Term ICRs of “a-” (Excellent) of Everest Group, Ltd. and Everest Reinsurance Holdings, Inc. (Delaware). Lastly, AM Best has affirmed the Long-Term Issue Credit Rating (Lon...
-

Securities Fraud Lawsuit Filed Against Lennar Corporation: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities class action lawsuit has been filed against Lennar Corporation ("Lennar" or the "Company") (NYSE: LEN) on behalf of investors who purchased or otherwise acquired Lennar Corporation securities from February 7, 2025 to October 2, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Triggs v. Lennar Corporation et al., filed on November 11, 2026 in the U.S. District Court Florida Southern District Court (Case No. 1:26-cv-28015). Lead...
-

Zai Lab Announces Participation in Investor Conferences in November 2026

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in November 2026: UBS Global Biopharma Conference Date: November 17, 2026 Event Format: 1-on-1 meetings only Location: London, UK Jefferies Global Healthcare Conference in London Date: November 18 and 19, 2026 Fireside Chat: Wednesday, November 18, 2026 at 10:30AM GMT Event Format: Pre...
-

Lost Money on Cardinal Infrastructure Group Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 62.37% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--Cardinal Infrastructure Group Inc. ("Cardinal Infrastructure" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Cardinal Infrastructure Group Inc. (NASDAQ: CDNL), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Cardinal Infrast...
-

Syncora Guarantee Inc. Announces the Availability of Certain Financial Information

NEW YORK--(BUSINESS WIRE)--Syncora Guarantee Inc. (“Syncora Guarantee”) today announced that certain financial information of Syncora Guarantee has been made available on Syncora Guarantee's website (www.syncoraguarantee.com). The information posted is Syncora Guarantee’s Statutory Basis Financial Statements as of September 30, 2026 filed with the NAIC. About Syncora Guarantee Inc. Syncora Guarantee Inc. is a New York-domiciled insurance company that is a wholly owned subsidiary of Syncora Fina...
-

Siebert Reports Third Quarter 2026 Financial Results

MIAMI BEACH, Fla. & NEW YORK--(BUSINESS WIRE)--Siebert Financial Corp. (NASDAQ: SIEB) (“Siebert”), a diversified provider of financial services, today reported financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial and Operational Highlights* Advisory fees increased 38% to $1.1 million, compared with $0.8 million in the prior-year quarter. Principal transaction revenue increased 8% to $4.7 million, compared with $4.3 million in the prior-year quarter, pri...
-

Morgan Stanley Declares Dividends on Its Preferred Stock

NEW YORK--(BUSINESS WIRE)--Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Series A - $319.71 per share (equivalent to $0.319706 per Depositary Share) 10 Percent Non-Cumulative Non-Voting Perpetual Preferred Stock, Series C - $25.00 per share Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E - $455.21 per share (equivalent to $0.455208 per Depositary Share) Fix...
-

Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will participate in a fireside chat hosted by UBS on Thursday, November 19th, at 8:30 a.m. (ET). The live webcast of the presentation can be accessed via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, wi...
-

Chemtrade Logistics Income Fund Announces Results for the Third Quarter of 2026 and Tightens 2026 Adjusted EBITDA Guidance to Between $495 and $515 Million

TORONTO--(BUSINESS WIRE)--CHEMTRADE LOGISTICS ANNOUNCES RESULTS FOR THE THIRD QUARTER OF 2026 AND TIGHTENS 2026 ADJUSTED EBITDA GUIDANCE TO BETWEEN $495 AND $515 MILLION...